Complement factor C3 is not required for full expression of lupus nephritis in MRL/lpr mice

Author： Sekine H.   Colten H.   Garnier G.   Circolo A.   Gilkeson G.  

Publisher： Elsevier

ISSN： 0162-3109

Source： Immunopharmacology, Vol.49, Iss.1, 2000-08, pp. : 28-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Involvement of the peripheral benzodiazepine receptor in the development of rheumatoid arthritis in Mrl/lpr mice

By Bribes E.   Bourrie B.   Esclangon M.   Galiegue S.   Vidal H.   Casellas P.  

European Journal of Pharmacology, Vol. 452, Iss. 1, 2002-09 ,pp. : 111-122

Elsevier

Access to resources Recommend Favorite

Weekly pulse therapy of methotrexate improves survival compared with its daily administration in MRL/lpr mice

By Asanuma Y.   Nagai K.   Kato M.   Sugiura H.   Kawai S.  

European Journal of Pharmacology, Vol. 435, Iss. 2, 2002-01 ,pp. : 253-258

Elsevier

Access to resources Recommend Favorite

Role of the H‐2 haplotype in Fas‐intact lupus‐prone MRL mice: association with autoantibodies but not renal disease

By  

Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. : 2992-2995

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pulsed IV regimen: beneficial in lupus nephritis?

By  

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Animal Models of Lupus and Lupus Nephritis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2320-2349

Bentham Science Publishers

Access to resources Recommend Favorite